Phase I Cetuximab and Concurrent Radio-chemotherapy
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the MTD toxicity of standard dose cetuximab together with concurrent
individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine